Effect of artificial sweeteners on insulin resistance among type-2 diabetes mellitus patients.

Artificial sweeteners HOMA-IR diabetes mellitus glucose metabolism insulin resistance

Journal

Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 22 04 2019
revised: 04 12 2019
accepted: 12 12 2019
entrez: 29 2 2020
pubmed: 29 2 2020
medline: 29 2 2020
Statut: epublish

Résumé

Incidence of diabetes mellitus has increased over the past few years, mainly due to our eating habits and physical inactivity. This also includes the use of artificial sweetening agents which have broadly replaced other forms of sugars and have shown a paradoxical, negative effect on blood glucose. Ingestion of these artificial sweeteners (AS) results in the release of insulin from pancreas which is mistaken for glucose (due to their sweet taste). This increases the levels of insulin in blood eventually leading to decreased receptor activity due to insulin resistance. It is a crosssectional study that was conducted on patients diagnosed with type-2 diabetes mellitus of a tertiary care hospital in Central India. All the diabetics that presented in the OPD were divided into 2 groups based on whether they use AS (group A) or not (group B). Insulin resistance was calculated for each group using HOMA-IR and graphs were plotted. The HOMAIR values for Group A and B ranged from 0.9-24.33 and 0.12-10.83 with mean values 7.39 and 2.6, respectively, showing that the ones who used AS had a higher insulin resistance. The study also showed that the duration of use of artificial sweeteners had a direct impact on insulin resistance.

Identifiants

pubmed: 32110567
doi: 10.4103/jfmpc.jfmpc_329_19
pii: JFMPC-9-69
pmc: PMC7014832
doi:

Types de publication

Journal Article

Langues

eng

Pagination

69-71

Informations de copyright

Copyright: © 2020 Journal of Family Medicine and Primary Care.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Nutrients. 2019 Apr 19;11(4):
pubmed: 31010163
Br J Nutr. 2014 Sep 14;112(5):725-34
pubmed: 24932880
Am J Clin Nutr. 2011 Jun;93(6):1321-7
pubmed: 21430119
Am J Clin Nutr. 2018 Sep 1;108(3):485-491
pubmed: 30535090
Eur J Endocrinol. 2016 Dec;175(6):605-614
pubmed: 27926472
Am J Clin Nutr. 2012 Sep;96(3):640-6
pubmed: 22854409
Diabetes Care. 2004 Jun;27(6):1487-95
pubmed: 15161807
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Diabetes Care. 2013 Sep;36(9):2530-5
pubmed: 23633524

Auteurs

Kushagra Mathur (K)

Medical Intern, Department of Pharmacology, Jawaharlal Nehru Medical College, Sawangi, Maharashtra, India.

Rajat Kumar Agrawal (RK)

Medical Intern, Department of Pharmacology, Jawaharlal Nehru Medical College, Sawangi, Maharashtra, India.

Shailesh Nagpure (S)

Professor, Department of Pharmacology, Jawaharlal Nehru Medical College, Sawangi, Maharashtra, India.

Deepali Deshpande (D)

Laboratory Assistant, Central Research Laboratory, Jawaharlal Nehru Medical College, Sawangi, Maharashtra, India.

Classifications MeSH